1. 705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1). (10th December 2020) Authors: MacKinnon, Andrew; Bhupathi, Deepthi; Chen, Jason; Huang, Tony; Li, Weiqun; Ma, Yong; Sotirovska, Natalija; Steggerda, Susanne; Zhang, Winter; Parlati, Francesco Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗